NEOVACS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0283 EUR | +0.71% |
|
-19.14% | -98.58% |
| 06-17 | Neovacs: collaboration agreement with CNRS | CF |
| 06-10 | Neovacs: presents results from vaccine candidates | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEOVACS | Other Biotechnology & Medical Research | +0.71% | -19.14% | -98.58% | -100.00% | -100.00% | 120K |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALNEV Stock
- Charts NEOVACS
- Comparison Chart
